🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: cycle 3: fasted

Found 78 matching trials

TGRX-326 Pharmacokinetic Food Effect Bioavailability Study

PHASE1

A study evaluating the effects of food intake on the pharmacokinetic (PK) p...

Status

Completed

Location

First Affiliated Hospital Bengbu Medical College

Start Date

2023-12-13

Trial ID

NCT06304805

Treatments Being Tested

cycle 1: treatment drug cycle 1: reference drug cycle 1: fasted cycle 1: food cycle 2: treatment drug cycle 2: reference drug cycle 2: fasted cycle 2: food cycle 3: treatment drug cycle 3: reference drug cycle 3: fasted cycle 3: food

Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin

PHASE1

The objectives of this study are (a) to determine if drug levels from a sin...

Status

Completed

Location

Pharmaceutical Research Unit

Start Date

2014-06

Trial ID

NCT02157649

Treatments Being Tested

IR Tablet under Fasted conditions ER Tablet under Fed Conditions ER Tablet under Fasted Conditions

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

PHASE1

This study is an open-label, randomized, single dose, multi-stage, cross-ov...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-11-06

Trial ID

NCT01495026

Treatments Being Tested

Dutasteride (0.5mg, fasted state)Dutasteride (0.5mg, fed state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state)Harnal-D Tablets with water (fasted state)Harnal-D Tablets with water (fed state)Harnal-D tablets without water (fasted state)

A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult Participants

PHASE1

The purpose of this study is to assess the rate and extent of absorption of...

Status

Completed

Location

SGS Life Science Services

Start Date

2017-02-14

Trial ID

NCT03023852

Treatments Being Tested

JNJ-63623872 Oseltamivir

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

PHASE1

The purpose of the study was to characterize the safety of investigational ...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2002-11

Trial ID

NCT01469052

Treatments Being Tested

AG-013736 AG-013736 AG-013736 AG-013736 AG-013736 AG-013736

Study of ASTX029 in Subjects With Advanced Solid Tumors

PHASE1

This study is a first-in-human, open-label, multicenter, Phase 1-2 study to...

Status

Completed

Location

City of Hope Comprehensive Cancer Center

Start Date

2018-05-07

Trial ID

NCT03520075

Treatments Being Tested

ASTX029 ASTX029

Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer

PHASE1

The study was an open-label, parallel-group, fixed-sequence study in male a...

Status

Completed

Location

Arensia Exploratory Medicine Llc

Start Date

2019-05-29

Trial ID

NCT03994211

Treatments Being Tested

pamiparib 60 mg pamiparib 20 mg itraconazole rifampin pamiparib

Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa

PHASE1

One purpose of this study is to determine if taking droxidopa after eating ...

Status

Completed

Location

Cetero Research

Start Date

2010-07

Trial ID

NCT01149629

Treatments Being Tested

Droxidopa Droxidopa Droxidopa

A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors

PHASE1

This multicenter, open-label study will evaluate the effect of posaconazole...

Status

Completed

Location

Multiple Locations

Start Date

2013-08

Trial ID

NCT01901172

Treatments Being Tested

RO5503781 RO5503781 RO5503781 RO5503781 posaconazole

Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants

PHASE1

The purpose of this study was to assess the safety, tolerability, and pharm...

Status

Terminated

Location

Multiple Locations

Start Date

2016-05-05

Trial ID

NCT02769065

Treatments Being Tested

TAK-071 Donepezil TAK-071 Placebo Donepezil Placebo

Previous Next